{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:51:50Z","timestamp":1793047910535,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004441","name":"the Swedish International Development Cooperation Agency","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004441","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Assar Gabrielsson Foundation"},{"name":"the Wilhelm and Martina Lundgren Foundation"},{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Chronic infection by human papillomavirus (HPV) is necessary for the development of almost all cervical cancers. The study assessed the prevalence of vaginal and cervical HPV infections in women living with HIV (WLWH) in Rwanda and assessed the performance of vaginal HPV screening to detect cervical HPV infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HIV-positive women (<jats:italic>N<\/jats:italic>\u2009=\u2009413) attending the HIV clinic at the University Teaching Hospital of Kigali, Kigali, Rwanda, were interviewed and vaginal and cervical swab samples for HPV testing and a pap smear sample were taken. RT-PCR was performed to detect twelve high-risk (HR)-HPVs (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59 and two low-risk (LR)-HPVs (HPV6 and 11) and conventional cytology was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Vaginal HR-HPV\/LR-HPV infections occurred in 39.2%\/4.4% of women, while cervical HR-HPV\/LR-HPV infections occurred in 38.3%\/4.8% of women. HPV58 (14.3%\/13.5%), HPV52 (12.5%\/12.4%), HPV51 (12.9%\/11.7%) and HPV16 (9.9%\/11.3%) were the most prevalent HPV infections in the vagina\/cervix and one third of HPV-positive women were infected with more than one HPV type. Normal cytology was less common in women with cervical HR-HPV infections compared to HPV-negative women (75.8% and 87.9%, respectively, <jats:italic>p<\/jats:italic>\u2009=\u20090.032). The type-specific HPV agreement for all HPV types between vaginal and cervical samples was 98.4% (kappa: 0.82\u2009\u00b1\u20090.02; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Screening for vaginal HPVs gave a sensitivity of 83.5% (confidence interval: 78.4\u201387.7), specificity of 99.1% (98.8\u201399.3%), positive predictive value of 81.6% (77.0\u201385.5%) and negative predictive value of 99.2% (99.0\u201399.4%) for cervical HPV infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>HR-HPVs are common in WLWH in Rwanda. Vaginal HPV testing may potentially be used to simplify cervical cancer screening in the future in Rwanda.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12879-025-10840-7","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T18:12:26Z","timestamp":1744740746000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["High Concordance between Vaginal Samples and Cervical Samples of Human Papillomavirus in Women Living with HIV in Rwanda"],"prefix":"10.1186","volume":"25","author":[{"given":"Schifra","family":"Uwamungu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethelehem Nigussie","family":"Zewdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude Mambo","family":"Muvunyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Bienvenu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengt","family":"Hass\u00e9us","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"issue":"1","key":"10840_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41416-020-0831-9","volume":"123","author":"E Jedy-Agba","year":"2020","unstructured":"Jedy-Agba E, Joko WY, Liu B, Buziba NG, Borok M, Korir A, Masamba L, Manraj SS, Finesse A, Wabinga H, et al. Trends in cervical cancer incidence in sub-Saharan Africa. Br J Cancer. 2020;123(1):148\u201354.","journal-title":"Br J Cancer"},{"issue":"Suppl 5","key":"10840_CR2","doi-asserted-by":"publisher","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H De Vuyst","year":"2013","unstructured":"De Vuyst H, Alemany L, Lacey C, Chibwesha CJ, Sahasrabuddhe V, Banura C, Denny L, Parham GP. The burden of human papillomavirus infections and related diseases in sub-saharan Africa. Vaccine. 2013;31(Suppl 5):F32-46.","journal-title":"Vaccine"},{"key":"10840_CR3","unstructured":"Global Cancer Observatory-International Agency for Research on Cancer-World Health Organization. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/646-rwanda-fact-sheet.pdf."},{"key":"10840_CR4","doi-asserted-by":"crossref","unstructured":"Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995,87(11):796\u2013802.","DOI":"10.1093\/jnci\/87.11.796"},{"key":"10840_CR5","doi-asserted-by":"crossref","unstructured":"Uwamungu S, Nigussie B, Muvunyi CM, Hasseus B, Andersson M, Giglio D. Prevalence of human papillomavirus in different mucous membranes in HIV concordant couples in Rwanda. Viruses. 2023,15(4).\u00a0PMID: 37112984.","DOI":"10.3390\/v15041005"},{"issue":"6","key":"10840_CR6","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1002\/ijc.32491","volume":"146","author":"T Mpunga","year":"2020","unstructured":"Mpunga T, Chantal Umulisa M, Tenet V, Rugwizangoga B, Milner DA Jr, Munyanshongore C, Heideman DAM, Bleeker MCG, Tommasino M, Franceschi S, et al. Human papillomavirus genotypes in cervical and other HPV-related anogenital cancer in Rwanda, according to HIV status. Int J Cancer. 2020;146(6):1514\u201322.","journal-title":"Int J Cancer"},{"issue":"2","key":"10840_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/hiv.12564","volume":"19","author":"M Mukanyangezi","year":"2018","unstructured":"Mukanyangezi M, Sengpiel V, Manzi O, Tobin G, Rulisa S, Bienvenu E, Giglio D. Screening for human papillomavirus, cervical cytological abnormalities and associated risk factors in HIV-positive and HIV-negative women in Rwanda. HIV Med. 2018;19(2):152\u201366.","journal-title":"HIV Med"},{"issue":"1","key":"10840_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12879-016-1539-6","volume":"16","author":"F Ngabo","year":"2016","unstructured":"Ngabo F, Franceschi S, Baussano I, Umulisa MC, Snijders PJF, Uyterlinde AM, Lazzarato F, Tenet V, Gatera M, Binagwaho A, et al. Human papillomavirus infection in Rwanda at the moment of implementation of a national HPV vaccination programme. BMC Infect Dis. 2016;16(1):225.","journal-title":"BMC Infect Dis"},{"key":"10840_CR9","unstructured":"WHO-IACR Cancer Today-Rwanda Globocan 2022. https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/646-rwanda-fact-sheet.pdf."},{"issue":"2","key":"10840_CR10","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Glob Health"},{"issue":"10167","key":"10840_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","volume":"393","author":"PA Cohen","year":"2019","unstructured":"Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169\u201382.","journal-title":"Lancet"},{"key":"10840_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2021.100810","volume":"37","author":"C Nkurunziza","year":"2021","unstructured":"Nkurunziza C, Ghebre R, Magriples U, Ntasumbumuyange D, Bazzett-Matabele L. Healthcare provider challenges to early detection of cervical cancer at primary healthcare level in Rwanda. Gynecol Oncol Rep. 2021;37: 100810.","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"10840_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13643-018-0874-7","volume":"7","author":"W Mapanga","year":"2018","unstructured":"Mapanga W, Girdler-Brown B, Feresu SA, Chipato T, Singh E. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review. Syst Rev. 2018;7(1):198.","journal-title":"Syst Rev"},{"key":"10840_CR14","doi-asserted-by":"crossref","unstructured":"Campos KLMd, Machado AP, Almeida FGd, Bonin CM, Prata TTM, Almeida LZ, Padovani CTJ, Ferreira AMT, Fernandes CEdS, Tozetti IA. Good agreements between self and clinician-collected specimens for the detection of human papillomavirus in Brazilian patients. Mem\u00f3rias do Instituto Oswaldo Cruz. 2014:109.\u00a0PMID: 24831549.","DOI":"10.1590\/0074-0276130397"},{"issue":"1","key":"10840_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12985-023-02073-4","volume":"20","author":"T Li","year":"2023","unstructured":"Li T, Chen S, Li X, Wu Z, Zhao Y, Cui J, Liu B, Chen F, Zhang X, Qiao Y, et al. The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening. Virology Journal. 2023;20(1):116.","journal-title":"Virology Journal"},{"issue":"8","key":"10840_CR16","first-page":"4183","volume":"37","author":"A Katrin Christine","year":"2017","unstructured":"Katrin Christine A, Anna JH, Henrik B, Lotten D, Christer B. Vaginal and Urine Self-sampling Compared to Cervical Sampling for HPV-testing with the Cobas 4800 HPV Test. Anticancer Res. 2017;37(8):4183.","journal-title":"Anticancer Res"},{"issue":"1","key":"10840_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12879-018-3254-y","volume":"18","author":"M Tranberg","year":"2018","unstructured":"Tranberg M, Jensen JS, Bech BH, Blaak\u00e6r J, Svanholm H, Andersen B. Good concordance of HPV detection between cervico-vaginal self-samples and general practitioner-collected samples using the Cobas 4800 HPV DNA test. BMC Infect Dis. 2018;18(1):348.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10840_CR18","doi-asserted-by":"publisher","first-page":"E44","DOI":"10.1111\/1469-0691.12063","volume":"19","author":"C Tamalet","year":"2013","unstructured":"Tamalet C, Le Retraite L, Leandri FX, Heid P, Garnier HS, Piana L. Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening. Clin Microbiol Infect. 2013;19(1):E44-e50.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10840_CR19","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ijc.25974","volume":"129","author":"PE Gravitt","year":"2011","unstructured":"Gravitt PE, Belinson JL, Salmeron J, Shah KV. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer. 2011;129(3):517\u201327.","journal-title":"Int J Cancer"},{"issue":"6","key":"10840_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020484","volume":"8","author":"AK Mezei","year":"2018","unstructured":"Mezei AK, Pedersen HN, Sy S, Regan C, Mitchell-Foster SM, Byamugisha J, Sekikubo M, Armstrong H, Rawat A, Singer J, et al. Community-based HPV self-collection versus visual inspection with acetic acid in Uganda: a cost-effectiveness analysis of the ASPIRE trial. BMJ Open. 2018;8(6): e020484.","journal-title":"BMJ Open"},{"key":"10840_CR21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1200\/GO.20.00598","volume":"7","author":"JJ Katanga","year":"2021","unstructured":"Katanga JJ, Rasch V, Manongi R, Pembe AB, Mwaiselage JD, Kjaer SK. Concordance in HPV Detection Between Self-Collected and Health Provider-Collected Cervicovaginal Samples Using careHPV in Tanzanian Women. JCO Glob Oncol. 2021;7:985\u201391.","journal-title":"JCO Glob Oncol"},{"issue":"2","key":"10840_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.9745\/GHSP-D-18-00206","volume":"6","author":"SL Silkensen","year":"2018","unstructured":"Silkensen SL, Schiffman M, Sahasrabuddhe V, Flanigan JS. Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening? Glob Health Sci Pract. 2018;6(2):242\u20136.","journal-title":"Glob Health Sci Pract"},{"issue":"6","key":"10840_CR23","doi-asserted-by":"publisher","first-page":"e411","DOI":"10.1016\/S2468-2667(23)00076-2","volume":"8","author":"PK Pretsch","year":"2023","unstructured":"Pretsch PK, Spees LP, Brewer NT, Hudgens MG, Sanusi B, Rohner E, Miller E, Jackson SL, Barclay L, Carter A, et al. Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): a phase 3, open-label, randomised controlled trial. Lancet Public Health. 2023;8(6):e411\u201321.","journal-title":"Lancet Public Health"},{"key":"10840_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2023.107571","volume":"173","author":"R Ibanez","year":"2023","unstructured":"Ibanez R, Roura E, Acera A, Andujar M, Pavon MA, Bruni L, de Sanjose S. HPV self-sampling among cervical cancer screening users in Spain: A randomized clinical trial of on-site training to increase the acceptability. Prev Med. 2023;173: 107571.","journal-title":"Prev Med"},{"issue":"11","key":"10840_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/OLQ.0b013e318064c8c5","volume":"34","author":"PE Castle","year":"2007","unstructured":"Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD. A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis. 2007;34(11):849\u201355.","journal-title":"Sex Transm Dis"},{"key":"10840_CR26","doi-asserted-by":"crossref","unstructured":"Okodo M, Okayama K, Sasagawa T, Teruya K, Settsu R, Mizuno S, Ishii Y, Oda M. Preferential Tissue Sites of Different Cancer-Risk Groups of Human Papillomaviruses. Int J Mol Sci. 2023,24(17).\u00a0PMID: 37685959.","DOI":"10.3390\/ijms241713151"},{"key":"10840_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virol.2018.01.002","volume":"516","author":"Z Chen","year":"2018","unstructured":"Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, et al. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology. 2018;516:86\u2013101.","journal-title":"Virology"},{"issue":"4","key":"10840_CR28","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jcv.2007.09.009","volume":"40","author":"M Lindh","year":"2007","unstructured":"Lindh M, Gorander S, Andersson E, Horal P, Mattsby-Balzer I, Ryd W. Real-time Taqman PCR targeting 14 human papilloma virus types. J Clin Virol. 2007;40(4):321\u20134.","journal-title":"J Clin Virol"},{"issue":"4","key":"10840_CR29","first-page":"243","volume":"60","author":"K Syrjanen","year":"1984","unstructured":"Syrjanen K, Vayrynen M, Castren O, Yliskoski M, Mantyjarvi R, Pyrhonen S, Saarikoski S. Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis. 1984;60(4):243\u20138.","journal-title":"Br J Vener Dis"},{"key":"10840_CR30","doi-asserted-by":"crossref","unstructured":"Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health. 2008,43(4 Suppl):S5\u201325, S25 e21\u201341.","DOI":"10.1016\/j.jadohealth.2008.07.009"},{"issue":"24","key":"10840_CR31","doi-asserted-by":"publisher","first-page":"10809","DOI":"10.7314\/APJCP.2014.15.24.10809","volume":"15","author":"P Nilyanimit","year":"2014","unstructured":"Nilyanimit P. Comparison of detection sensitivity for human papillomavirus between self-collected vaginal swabs and physician-collected cervical swabs by electrochemical DNA chip. Asian Pac J Cancer Prev. 2014;15(24):10809\u201312.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"10840_CR32","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12905-023-02215-4","volume":"23","author":"JV Solnaes","year":"2023","unstructured":"Solnaes JV, Njor SH, Tranberg M. Does full HPV genotyping perform similarly well in clinician-collected cervical samples and self-collected vaginal samples when using the CLART HPV4S assay? BMC Womens Health. 2023;23(1):78.","journal-title":"BMC Womens Health"},{"issue":"1","key":"10840_CR33","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e8","volume":"29","author":"L Coorevits","year":"2018","unstructured":"Coorevits L, Traen A, Binge L, Van Dorpe J, Praet M, Boelens J, Padalko E. Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing? J Gynecol Oncol. 2018;29(1): e8.","journal-title":"J Gynecol Oncol"},{"key":"10840_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2021.105017","volume":"145","author":"J Joseph","year":"2021","unstructured":"Joseph J, Mangwendeza P, Maparo T, Mhizha T, Demke O, Murwira S, Dickson H, Madzima B, Khan S. Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe. J Clin Virol. 2021;145: 105017.","journal-title":"J Clin Virol"},{"issue":"1","key":"10840_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12905-023-02342-y","volume":"23","author":"DW Nang","year":"2023","unstructured":"Nang DW, Tukirinawe H, Okello M, Tayebwa B, Theophilus P, Sikakulya FK, Fajardo Y, Afodun AM, Kajabwangu R. Prevalence of high-risk human papillomavirus infection and associated factors among women of reproductive age attending a rural teaching hospital in western Uganda. BMC Women\u2019s Health. 2023;23(1):209.","journal-title":"BMC Women\u2019s Health"},{"issue":"18","key":"10840_CR36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.21037\/atm-20-5832","volume":"8","author":"J Liu","year":"2020","unstructured":"Liu J, Luo M, Zhang Y, Cao G, Wang S. Association of high-risk human papillomavirus infection duration and cervical lesions with vaginal microbiota composition. Annals of Translational Medicine. 2020;8(18):1161.","journal-title":"Annals of Translational Medicine"},{"issue":"3","key":"10840_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jinf.2012.10.024","volume":"66","author":"C Chelimo","year":"2013","unstructured":"Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect. 2013;66(3):207\u201317.","journal-title":"J Infect"},{"issue":"1","key":"10840_CR38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12879-022-07215-7","volume":"22","author":"NT Cosmas","year":"2022","unstructured":"Cosmas NT, Nimzing L, Egah D, Famooto A, Adebamowo SN, Adebamowo CA. Prevalence of vaginal HPV infection among adolescent and early adult girls in Jos, North-Central Nigeria. BMC Infect Dis. 2022;22(1):340.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10840_CR39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12985-022-01850-x","volume":"19","author":"H Li","year":"2022","unstructured":"Li H, Xiao Z, Xing B, Wu S, Wang Y, Liu Z, Zeng Y, Mushi JC, Sun H, Li P. Association between common vaginal and HPV infections and results of cytology test in the Zhoupu District, Shanghai City, China, from 2014 to 2019. Virology Journal. 2022;19(1):127.","journal-title":"Virology Journal"},{"issue":"5","key":"10840_CR40","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1139::AID-CNCR18>3.0.CO;2-8","volume":"85","author":"AB Moscicki","year":"1999","unstructured":"Moscicki AB, Burt VG, Kanowitz S, Darragh T, Shiboski S. The significance of squamous metaplasia in the development of low grade squamous intraepithelial lesions in young women. Cancer. 1999;85(5):1139\u201344.","journal-title":"Cancer"},{"issue":"4","key":"10840_CR41","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/infdis\/jis398","volume":"206","author":"LY Hwang","year":"2012","unstructured":"Hwang LY, Ma Y, Shiboski SC, Farhat S, Jonte J, Moscicki AB. Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. J Infect Dis. 2012;206(4):504\u201311.","journal-title":"J Infect Dis"},{"key":"10840_CR42","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2147\/IJWH.S218441","volume":"11","author":"Y Itarat","year":"2019","unstructured":"Itarat Y, Kietpeerakool C, Jampathong N, Chumworathayi B, Kleebkaow P, Aue-Aungkul A, Nhokaew W. Sexual behavior and infection with cervical human papillomavirus types 16 and 18. Int J Womens Health. 2019;11:489\u201394.","journal-title":"Int J Womens Health"},{"issue":"1","key":"10840_CR43","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12978-021-01244-2","volume":"18","author":"NL Kops","year":"2021","unstructured":"Kops NL, Caier\u00e3o J, Bessel M, Horvath JDC, Domingues CM, Benzaken AS, Villa LL, de Souza FMA, Pereira GFM, Wendland EM. Behavioral factors associated with multiple-type HPV genital infections: data from a cross-sectional study in young women in Brazil. Reprod Health. 2021;18(1):201.","journal-title":"Reprod Health"},{"issue":"1","key":"10840_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1186\/s12885-022-09964-9","volume":"22","author":"TA Tiiti","year":"2022","unstructured":"Tiiti TA, Selabe SG, Bogers J, Lebelo RL. High prevalence of and factors associated with human papillomavirus infection among women attending a tertiary hospital in Gauteng Province, South Africa. BMC Cancer. 2022;22(1):854.","journal-title":"BMC Cancer"},{"issue":"8","key":"10840_CR45","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00384-014-1922-y","volume":"29","author":"R Kaderli","year":"2014","unstructured":"Kaderli R, Schn\u00fcriger B, Br\u00fcgger LE. The impact of smoking on HPV infection and the development of anogenital warts. Int J Colorectal Dis. 2014;29(8):899\u2013908.","journal-title":"Int J Colorectal Dis"},{"key":"10840_CR46","doi-asserted-by":"crossref","unstructured":"Ma* K, Li* S, Wu S, Zhu J, Yang Y. Impact of smoking exposure on human papillomavirus clearance among Chinese women: A follow-up propensity score matching study. Tob Induc Dis. 2023,21(March):1\u201311.","DOI":"10.18332\/tid\/161026"},{"key":"10840_CR47","doi-asserted-by":"publisher","first-page":"5829676","DOI":"10.1155\/2019\/5829676","volume":"2019","author":"SS Seo","year":"2019","unstructured":"Seo SS, Oh HY, Kim MK, Lee DO, Chung YK, Kim JY, Lee CW. Combined Effect of Secondhand Smoking and Alcohol Drinking on Risk of Persistent Human Papillomavirus Infection. Biomed Res Int. 2019;2019:5829676.","journal-title":"Biomed Res Int"},{"issue":"1","key":"10840_CR48","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1186\/s12889-024-20389-w","volume":"24","author":"ZC Meda","year":"2024","unstructured":"Meda ZC, Hien H, Traore TI, Ouattara CA, Ramde Z, Ilboudo B, Some A, Ouattara S. Factors associated with positive human papillomavirus (HPV) test results in cervical precancer screening: a cross-sectional study at Souro Sanou National Teaching Hospital (SSNTH) in Bobo Dioulasso, Burkina Faso. BMC Public Health. 2024;24(1):2900.","journal-title":"BMC Public Health"},{"issue":"2","key":"10840_CR49","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1128\/JCM.01322-07","volume":"46","author":"DJ Marais","year":"2008","unstructured":"Marais DJ, Constant D, Allan B, Carrara H, Hoffman M, Shapiro S, Morroni C, Williamson AL. Cervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women. J Clin Microbiol. 2008;46(2):732\u20139.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10840_CR50","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12885-024-11928-0","volume":"24","author":"H Nakigozi","year":"2024","unstructured":"Nakigozi H, Ndejjo R, Bazeyo W, Nabaggala A, Achola C, Iga M, Kalyesubula S, Kanamwangi B, Mutungi G, Batte C, et al. Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda. BMC Cancer. 2024;24(1):243.","journal-title":"BMC Cancer"},{"issue":"1","key":"10840_CR51","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12916-023-02965-w","volume":"21","author":"SJ Bowden","year":"2023","unstructured":"Bowden SJ, Doulgeraki T, Bouras E, Markozannes G, Athanasiou A, Grout-Smith H, Kechagias KS, Ellis LB, Zuber V, Chadeau-Hyam M, et al. Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: an umbrella review and follow-up Mendelian randomisation studies. BMC Med. 2023;21(1):274.","journal-title":"BMC Med"},{"issue":"1","key":"10840_CR52","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e14","volume":"29","author":"YT Ouh","year":"2018","unstructured":"Ouh YT, Min KJ, Cho HW, Ki M, Oh JK, Shin SY, Hong JH, Lee JK. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014\u20132016. J Gynecol Oncol. 2018;29(1): e14.","journal-title":"J Gynecol Oncol"},{"key":"10840_CR53","first-page":"2897937","volume":"2018","author":"X Wang","year":"2018","unstructured":"Wang X, Zeng Y, Huang X, Zhang Y. Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast China. Biomed Res Int. 2018;2018:2897937.","journal-title":"Biomed Res Int"},{"issue":"1","key":"10840_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12905-023-02166-w","volume":"23","author":"H Luan","year":"2023","unstructured":"Luan H. Human papilloma virus infection and its associated risk for cervical lesions: a cross-sectional study in Putuo area of Shanghai, China. BMC Women\u2019s Health. 2023;23(1):28.","journal-title":"BMC Women\u2019s Health"},{"issue":"1","key":"10840_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12985-023-01959-7","volume":"20","author":"W Zhang","year":"2023","unstructured":"Zhang W, Guo N, Li B, Shang E, Wang J, Zhang M, Yang X. Prevalence and genotype distribution of human papillomavirus infections in Beijing, China between 2016 and 2020. Virology Journal. 2023;20(1):11.","journal-title":"Virology Journal"},{"issue":"1","key":"10840_CR56","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0090-8258(03)00176-8","volume":"90","author":"O Abulafia","year":"2003","unstructured":"Abulafia O, Pezzullo JC, Sherer DM. Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol. 2003;90(1):137\u201344.","journal-title":"Gynecol Oncol"},{"key":"10840_CR57","doi-asserted-by":"crossref","unstructured":"Enebe JT, Dim CC, Nnakenyi EF, Ezegwui HU, Ozumba BC. Effect of Low CD4 Cell Count on Cervical Squamous Intraepithelial Lesions among HIV-Positive Women in Enugu, Southeastern Nigeria. J Clin Diagn Res. 2015,9(11):QC07\u201310.","DOI":"10.7860\/JCDR\/2015\/14808.6785"},{"issue":"3","key":"10840_CR58","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/157016211795945214","volume":"9","author":"KP McKenzie","year":"2011","unstructured":"McKenzie KP, Rogers RK, Njoroge JW, John-Stewart G, Richardson BA, Mugo NR, De Vuyst H, Pamnani RN, Rana FS, Warui D, et al. Cervical squamous intraepithelial lesions among HIV-positive women on antiretroviral therapy in Kenya. Curr HIV Res. 2011;9(3):180\u20135.","journal-title":"Curr HIV Res"},{"issue":"10","key":"10840_CR59","first-page":"333","volume":"91","author":"J Wanyoike-Gichuhi","year":"2014","unstructured":"Wanyoike-Gichuhi J, Kayumba P, Khisa W. Prevalence of Cervical Cytology Abnormalities among Hiv Infected Women at Rwanda Military Hospital. East Afr Med J. 2014;91(10):333\u201340.","journal-title":"East Afr Med J"},{"issue":"7","key":"10840_CR60","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1128\/JCM.02440-05","volume":"44","author":"AA Brink","year":"2006","unstructured":"Brink AA, Meijer CJ, Wiegerinck MA, Nieboer TE, Kruitwagen RF, van Kemenade F, Fransen Daalmeijer N, Hesselink AT, Berkhof J, Snijders PJ. High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush. J Clin Microbiol. 2006;44(7):2518\u201323.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10840_CR61","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12905-020-01158-4","volume":"21","author":"A Kamath Mulki","year":"2021","unstructured":"Kamath Mulki A, Withers M. Human Papilloma Virus self-sampling performance in low- and middle-income countries. BMC Women\u2019s Health. 2021;21(1):12.","journal-title":"BMC Women\u2019s Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10840-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10840-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T19:03:18Z","timestamp":1744743798000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10840-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10840"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10840-7","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Rwanda National Ethics Committee and the Swedish Ethical Review Authority (No. 43\/RNEC\/2021, No. 49\/RNEC\/2023 and Dnr. 2021\u201302464). Informed consent was provided from all participants in the study. The study adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DG has served on scientific advisory boards and scientific presentations for Merck, Roche and AstraZeneca. The other others declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"527"}}